Literature DB >> 2721006

Aberrant free radical activity in cystic fibrosis.

B Salh1, K Webb, P M Guyan, J P Day, D Wickens, J Griffin, J M Braganza, T L Dormandy.   

Abstract

It has been suggested that the molar ratio of octadeca 9,11 dienoic acid to linoleic acid in biological material provides an index of activity along the non-peroxide pathway of a free radical attack on polyunsaturated fatty acids. In 17 adults with cystic fibrosis the 'molar ratio' in nasal epithelial cells--a recognised target of the disease--exceeded that in 20 controls (median 2.09%, range 1.70-3.01% versus 1.56, 0.92-2.23%, p = 0.0002). The difference was also apparent, although less stark, upon analysis of serum in a further 22 CF patients (2.48%, 1.60-5.24%) and 25 controls (1.96%, 0.81-3.90%, p = 0.0348). There was no correlation between the 'molar ratio' and blood white cell count or erythrocyte sedimentation rate, severity of lung or liver disease, indicating that the raised values are a primary feature, rather than reflecting disease severity. Aberrant free radical activity may underlie cellular dysfunction in cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2721006     DOI: 10.1016/0009-8981(89)90318-5

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

Review 1.  Role of free radicals in the pathogenesis of cystic fibrosis.

Authors:  R K Brown; F J Kelly
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

2.  Oxidative stress during acute respiratory exacerbations in cystic fibrosis.

Authors:  L T McGrath; P Mallon; L Dowey; B Silke; E McClean; M McDonnell; A Devine; S Copeland; S Elborn
Journal:  Thorax       Date:  1999-06       Impact factor: 9.139

3.  Variants in the glutamate-cysteine-ligase gene are associated with cystic fibrosis lung disease.

Authors:  Edward F McKone; Jing Shao; Daisy D Frangolias; Cassie L Keener; Cynthia A Shephard; Federico M Farin; Mark R Tonelli; Peter D Pare; Andrew J Sandford; Moira L Aitken; Terrance J Kavanagh
Journal:  Am J Respir Crit Care Med       Date:  2006-05-11       Impact factor: 21.405

4.  Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis.

Authors:  S Renner; R Rath; P Rust; S Lehr; T Frischer; I Elmadfa; I Eichler
Journal:  Thorax       Date:  2001-01       Impact factor: 9.139

5.  Toward an animal model of chronic pancreatitis. Pancreatobiliary secretion in hamsters on long-term treatment with chemical inducers of cytochromes P450.

Authors:  S C Rutishauser; A E Ali; I J Jeffrey; L P Hunt; J M Braganza
Journal:  Int J Pancreatol       Date:  1995-10

6.  Preliminary evidence for cell membrane amelioration in children with cystic fibrosis by 5-MTHF and vitamin B12 supplementation: a single arm trial.

Authors:  Cinzia Scambi; Lucia De Franceschi; Patrizia Guarini; Fabio Poli; Angela Siciliano; Patrizia Pattini; Andrea Biondani; Valentina La Verde; Oscar Bortolami; Francesco Turrini; Franco Carta; Ciro D'Orazio; Baroukh M Assael; Giovanni Faccini; Lisa M Bambara
Journal:  PLoS One       Date:  2009-03-11       Impact factor: 3.240

7.  Attenuation of oxidant-induced lung injury by 21-aminosteroids (lazaroids): correlation with the mRNA expression for E-selectin, P-selectin, ICAM-1, and VCAM-1.

Authors:  R L Griffin; R F Krzesicki; S F Fidler; C L Rosenbloom; J A Auchampach; A M Manning; J V Haas; S K Cammarata; J E Chin; I M Richards
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.